DK1353919T3 - Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme - Google Patents

Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme

Info

Publication number: DK1353919T3
Authority: DK; Denmark
Prior art keywords: same; compositions containing; medicinal compositions; quinuclidine derivatives; newly known
Prior art date: 2000-12-28

Application number

DK01986924T

Other languages

English (en)

Inventor

Forner Maria Dolors Fernandez

Albero Maria Antonia Buil

Quinones Maria Prat

Original Assignee

Almirall Prodesfarma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-28

Filing date

2001-12-20

Publication date

2006-11-20

2001-12-20 Application filed by Almirall Prodesfarma Ag filed Critical Almirall Prodesfarma Ag

2006-11-20 Application granted granted Critical

2006-11-20 Publication of DK1353919T3 publication Critical patent/DK1353919T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK01986924T 2000-12-28 2001-12-20 Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme DK1353919T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ES200003130		2000-12-28

Publications (1)

Publication Number	Publication Date
DK1353919T3 true DK1353919T3 (da)	2006-11-20

Family

ID=8496180

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01986924T DK1353919T3 (da)	2000-12-28	2001-12-20	Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme

Country Status (33)

Country	Link
US (4)	US7122558B2 (da)
EP (1)	EP1353919B1 (da)
JP (1)	JP4295985B2 (da)
KR (1)	KR100869721B1 (da)
CN (1)	CN1250545C (da)
AR (1)	AR032072A1 (da)
AT (1)	ATE334128T1 (da)
AU (1)	AU2002238471B2 (da)
BG (1)	BG66162B1 (da)
BR (1)	BR0116624A (da)
CA (1)	CA2433128C (da)
CY (1)	CY1105719T1 (da)
CZ (1)	CZ301209B6 (da)
DE (1)	DE60121813T2 (da)
DK (1)	DK1353919T3 (da)
EC (1)	ECSP034672A (da)
EE (1)	EE05404B1 (da)
ES (1)	ES2266291T3 (da)
HU (1)	HUP0303524A3 (da)
IL (2)	IL156558A0 (da)
MX (1)	MXPA03005862A (da)
MY (1)	MY136067A (da)
NO (1)	NO328772B1 (da)
NZ (1)	NZ526674A (da)
PE (1)	PE20020721A1 (da)
PL (1)	PL363807A1 (da)
PT (1)	PT1353919E (da)
RU (1)	RU2282629C2 (da)
SI (1)	SI1353919T1 (da)
SK (1)	SK287414B6 (da)
UA (1)	UA75626C2 (da)
WO (1)	WO2002053564A2 (da)
ZA (1)	ZA200305008B (da)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165768B1 (es)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
KR100869722B1 (ko)	2000-12-22	2008-11-21	알미랄 에이쥐	퀴누클리딘 카르바메이트 유도체 및 ｍ3 길항제로서 그의사용
NZ526674A (en) *	2000-12-28	2005-03-24	Almirall Prodesfarma Ag	Novel quinuclidine derivatives and medicinal compositions containing the same
GB0118373D0 (en) *	2001-07-27	2001-09-19	Glaxo Group Ltd	Novel therapeutic method
ES2203327B1 (es)	2002-06-21	2005-06-16	Almirall Prodesfarma, S.A.	Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
ES2204295B1 (es)	2002-07-02	2005-08-01	Almirall Prodesfarma, S.A.	Nuevos derivados de quinuclidina-amida.
BR0215801A (pt) *	2002-07-08	2005-05-10	Ranbaxy Lab Ltd	Derivados de 3,6-dissubstituìdos azabiciclo [3.1.0] hexano úteis como antagonistas de receptores muscarìnicos
WO2004014363A1 (en) *	2002-08-09	2004-02-19	Ranbaxy Laboratories Limited	3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonist
TW200800953A (en)	2002-10-30	2008-01-01	Theravance Inc	Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine
US7517905B2 (en)	2003-04-09	2009-04-14	Ranbaxy Laboratories Limited	Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
EA009387B1 (ru)	2003-04-11	2007-12-28	Рэнбакси Лабораториз Лимитед	Азабициклические производные в качестве антагонистов мускаринового рецептора
AR044134A1 (es) *	2003-05-02	2005-08-24	Novartis Ag	Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.
TW200519106A (en)	2003-05-02	2005-06-16	Novartis Ag	Organic compounds
CN100445281C (zh) *	2003-05-02	2008-12-24	诺瓦提斯公司	与毒蕈碱性m3受体结合的奎宁环衍生物
ATE435862T1 (de)	2003-05-28	2009-07-15	Theravance Inc	Azabicycloalkanverbindungen als muscarinrezeptor antagonisten
US7368463B2 (en)	2003-07-11	2008-05-06	Theravance, Inc.	Substituted 4-amino-1-benzylpiperidine compounds
US20050026887A1 (en) *	2003-07-29	2005-02-03	Boehringer Ingelheim International Gmbh	Medicaments for inhalation comprising an anticholinergic and a steroid
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
ES2239546B1 (es) *	2004-03-15	2006-12-01	Almirall Prodesfarma, S.A.	Nuevos esteres de quinuclidina cuaternizados.
PE20060259A1 (es)	2004-04-27	2006-03-25	Glaxo Group Ltd	Compuestos de quinuclidina como antagonistas del receptor de acetilcolina muscarinico
US7598267B2 (en) *	2004-05-13	2009-10-06	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
ES2257152B1 (es) *	2004-05-31	2007-07-01	Laboratorios Almirall S.A.	Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
SI1765404T1 (sl) *	2004-05-31	2009-04-30	Almirall Lab	Kombinacije, ki obsegajo antimuskarinska sredstva in beta-adrenergične agoniste
EP1797040A1 (en) *	2004-09-29	2007-06-20	Ranbaxy Laboratories Limited	Muscarinic receptor antagonists
GT200500281A (es)	2004-10-22	2006-04-24	Novartis Ag	Compuestos organicos.
CA2585122A1 (en) *	2004-10-25	2006-05-04	Schering Corporation	M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0507577D0 (en)	2005-04-14	2005-05-18	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
WO2007045979A1 (en)	2005-10-19	2007-04-26	Ranbaxy Laboratories Limited	Pharmaceutical compositions of muscarinic receptor antagonists
MY144906A (en)	2005-10-21	2011-11-30	Novartis Ag	Human antibodies against il13 and therapeutic uses
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
AR060607A1 (es)	2006-04-21	2008-07-02	Novartis Ag	Derivados de purina,composiciones farmaceuticas que los contienen, metodo de preparacion y usos en enfermedades obstructivas o inflamatorias de las vias respiratorias.
ES2298049B1 (es) *	2006-07-21	2009-10-20	Laboratorios Almirall S.A.	Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
BRPI0717564A2 (pt)	2006-09-29	2013-10-22	Novartis Ag	Pirazolopirimidinas como inibidores de pi3k lipídeo cinase
TW200825084A (en)	2006-11-14	2008-06-16	Astrazeneca Ab	New compounds 521
US20080176901A1 (en)	2007-01-10	2008-07-24	Irm Llc	Compounds and compositions as channel activating protease inhibitors
US8367696B2 (en)	2007-02-09	2013-02-05	Astellas Pharma Inc.	Aza-bridged-ring compound
EP2121688A1 (en) *	2007-02-15	2009-11-25	Argenta Discovery Ltd	Heterocyclic derivatives as m3 muscarinic receptors
AU2008248598B2 (en)	2007-05-07	2011-11-17	Novartis Ag	Organic compounds
PT2197841E (pt) *	2007-09-07	2012-01-02	Theravance Inc	Compostos contendo guanidina úteis como antagonistas do receptor muscarínico
CA2608561A1 (en) *	2007-10-29	2009-04-29	Carl Paluszkiewicz	Motorcycle wind deflector accessory support
ES2654395T3 (es)	2007-12-10	2018-02-13	Novartis Ag	Análogos de amilorida espirocíclicos como bloqueantes de ENaC
JP2011506477A (ja)	2007-12-14	2011-03-03	セラヴァンス，インコーポレーテッド	ムスカリン受容体拮抗薬として有用なアミジン含有化合物
JP5584138B2 (ja)	2008-01-11	2014-09-03	ノバルティスアーゲー	キナーゼ阻害剤としてのピリミジン類
EP2100599A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) *	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US8268834B2 (en)	2008-03-19	2012-09-18	Novartis Ag	Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
GB0808708D0 (en) *	2008-05-13	2008-06-18	Astrazeneca Ab	New compounds 274
GB0808707D0 (en) *	2008-05-13	2008-06-18	Argenta Discovery Ltd	New compounds 275
JP4837800B2 (ja)	2008-05-13	2011-12-14	アストラゼネカ・アクチエボラーグ	ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体
EP2300010B1 (en)	2008-06-10	2015-03-04	Novartis AG	Pyrazine derivatives as epithelial sodium channel blockers
US8263623B2 (en)	2008-07-11	2012-09-11	Pfizer Inc.	Triazol derivatives useful for the treatment of diseases
GB0814729D0 (en) *	2008-08-12	2008-09-17	Argenta Discovery Ltd	New combination
DK2391366T3 (da)	2009-01-29	2013-01-07	Novartis Ag	Substituerede benzimidazoler til behandling af astrocytomer
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
JP5781510B2 (ja)	2009-08-12	2015-09-24	ノバルティスアーゲー	ヘテロ環式ヒドラゾン化合物および癌および炎症の処置のためのそれらの使用
HRP20190016T1 (hr)	2009-08-17	2019-03-08	Intellikine, Llc	Heterociklički spojevi i njihova upotreba
MX2012002179A (es)	2009-08-20	2012-03-16	Novartis Ag	Compuestos heterociclicos de oxima.
MX2012004792A (es)	2009-10-22	2013-02-01	Vertex Pharma	Composiciones para el tratamiento de fibrosis quistica y otras enfermedades cronicas.
US8247436B2 (en)	2010-03-19	2012-08-21	Novartis Ag	Pyridine and pyrazine derivative for the treatment of CF
EP2386555A1 (en)	2010-05-13	2011-11-16	Almirall, S.A.	New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
UY33597A (es)	2010-09-09	2012-04-30	Irm Llc	Compuestos y composiciones como inhibidores de la trk
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
US8372845B2 (en)	2010-09-17	2013-02-12	Novartis Ag	Pyrazine derivatives as enac blockers
US20130324526A1 (en)	2011-02-10	2013-12-05	Novartis Ag	[1,2,4] triazolo [4,3-b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
JP5808826B2 (ja)	2011-02-23	2015-11-10	インテリカイン，エルエルシー	複素環化合物およびその使用
JP5959541B2 (ja)	2011-02-25	2016-08-02	ノバルティスアーゲー	Ｔｒｋ阻害剤としてのピラゾロ［１，５−ａ］ピリジン
EP2510928A1 (en)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium for use in improving the quality of sleep in respiratory patients
UY34305A (es)	2011-09-01	2013-04-30	Novartis Ag	Derivados de heterociclos bicíclicos para el tratamiento de la hipertensión arterial pulmonar
WO2013038362A1 (en)	2011-09-15	2013-03-21	Novartis Ag	6 - substituted 3 - (quinolin- 6 - ylthio) - [1,2,4] triazolo [4, 3 -a] pyradines as tyrosine kinase
US9034879B2 (en)	2011-09-16	2015-05-19	Novartis Ag	Heterocyclic compounds for the treatment of CF
WO2013038381A1 (en)	2011-09-16	2013-03-21	Novartis Ag	Pyridine/pyrazine amide derivatives
WO2013038378A1 (en)	2011-09-16	2013-03-21	Novartis Ag	Pyridine amide derivatives
ES2882807T3 (es)	2011-09-16	2021-12-02	Novartis Ag	Heterociclil carboxamidas N-sustituidas
WO2013038373A1 (en)	2011-09-16	2013-03-21	Novartis Ag	Pyridine amide derivatives
JP6130391B2 (ja)	2011-11-23	2017-05-17	インテリカイン，エルエルシー	Ｍｔｏｒ阻害剤を使用する強化された治療レジメン
US8809340B2 (en)	2012-03-19	2014-08-19	Novartis Ag	Crystalline form
WO2013149581A1 (en)	2012-04-03	2013-10-10	Novartis Ag	Combination products with tyrosine kinase inhibitors and their use
US9073921B2 (en)	2013-03-01	2015-07-07	Novartis Ag	Salt forms of bicyclic heterocyclic derivatives
HK1219421A1 (zh)	2013-03-15	2017-04-07	因特利凯有限责任公司	激酶抑制剂的组合及其用途
EP3023424B1 (en) *	2013-07-13	2019-02-27	Beijing Shuobai Pharmaceutical Co., Ltd.	Quinine compounds, and optical isomers, preparation method and medical use thereof
TW201605450A (zh)	2013-12-03	2016-02-16	諾華公司	Ｍｄｍ２抑制劑與ＢＲＡＦ抑制劑之組合及其用途
WO2015162461A1 (en)	2014-04-24	2015-10-29	Novartis Ag	Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
MX2016013812A (es)	2014-04-24	2017-03-09	Novartis Ag	Derivados de amino-pirazina como inhibidores de fosfatidil-inositol-3-cinasa.
EA201692140A1 (ru)	2014-04-24	2017-04-28	Новартис Аг	Производные аминопиридина в качестве ингибиторов фосфатидилинозитол 3-киназы
WO2016011658A1 (en)	2014-07-25	2016-01-28	Novartis Ag	Combination therapy
BR112017001695A2 (pt)	2014-07-31	2017-11-21	Novartis Ag	terapia de combinação
JP2022537667A (ja)	2019-06-10	2022-08-29	ノバルティスアーゲー	Ｃｆ、ｃｏｐｄ、及び気管支拡張症の治療のためのピリジン及びピラジン誘導体
EP4021572A1 (en)	2019-08-28	2022-07-06	Novartis AG	Substituted 1,3-phenyl heteroaryl derivatives and their use in the treatment of disease
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4465834A (en) *	1965-09-20	1984-08-14	Fmc Corporation	Anticholinergic drugs
GB1219606A (en) *	1968-07-15	1971-01-20	Rech S Et D Applic Scient Soge	Quinuclidinol derivatives and preparation thereof
US4082756A (en)	1971-04-16	1978-04-04	Colgate-Palmolive Company	Quaternary quinuclidinium carbamates and thiocarbamates
US4431627A (en)	1980-06-03	1984-02-14	Research Corporation	Gamma-emitting receptor-binding 3-quinuclidinyl glycolates; methods of preparation thereof and imaging and assay methods utilizing same
JPS57500735A (da) *	1980-06-03	1982-04-30
FR2539135B1 (fr) *	1983-01-11	1986-02-28	Essilor Int	Hydrogels de polyurethane et procede de fabrication
IL72788A (en) *	1984-08-28	1989-07-31	Israel State	Bis quaternary oxy-bis methylene(or trimethylene)bis-n-quinuclidines,pyridines and piperidines,their preparation and antidotes against organophosphorus and carbamate poisoning containing them
US4644003A (en) *	1985-04-03	1987-02-17	Research Corporation	3-quinuclidinol esters, useful as antagonists of muscarinic acetylcholine receptors
US4675326A (en) *	1985-05-08	1987-06-23	Gabriel Amitai	Bisquaternary antidotes
US4843074A (en) *	1988-05-17	1989-06-27	Marion Laboratories, Inc.	1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
IT1230881B (it) *	1989-06-20	1991-11-08	Angeli Inst Spa	Derivati del r(-) 3-chinuclidinolo
DE3931041C2 (de)	1989-09-16	2000-04-06	Boehringer Ingelheim Kg	Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
GB8923590D0 (en)	1989-10-19	1989-12-06	Pfizer Ltd	Antimuscarinic bronchodilators
DE69132735T2 (de) *	1990-09-06	2002-05-29	Pfizer Inc., New York	Anti-muscarin bronchodilatoren
DE4108393A1 (de) *	1991-03-15	1992-09-17	Boehringer Ingelheim Kg	Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
GB9119705D0 (en) *	1991-09-14	1991-10-30	Pfizer Ltd	Therapeutic compounds
EP0747355A4 (en)	1994-02-10	1997-04-09	Yamanouchi Pharma Co Ltd	NEW CARBAMATES AND MEDICINAL PRODUCTS CONTAINING THEM
NO2005012I1 (no) *	1994-12-28	2005-06-06	Debio Rech Pharma Sa	Triptorelin og farmasoytisk akseptable salter derav
WO1997013766A1 (en) *	1995-10-13	1997-04-17	Banyu Pharmaceutical Co., Ltd.	Substituted heteroaromatic derivatives
PE92198A1 (es)	1996-08-01	1999-01-09	Banyu Pharma Co Ltd	Derivados de 1,4-piperidina disustituida que contienen fluor
US7214687B2 (en) *	1999-07-14	2007-05-08	Almirall Ag	Quinuclidine derivatives and medicinal compositions containing the same
ES2165768B1 (es) *	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
EA005520B1 (ru)	2000-06-27	2005-04-28	Лабораториос С.А.Л.В.А.Т.,С.А.	Карбаматы, полученные из арилалкиламинов
KR100869722B1 (ko) *	2000-12-22	2008-11-21	알미랄 에이쥐	퀴누클리딘 카르바메이트 유도체 및 ｍ3 길항제로서 그의사용
NZ526674A (en) *	2000-12-28	2005-03-24	Almirall Prodesfarma Ag	Novel quinuclidine derivatives and medicinal compositions containing the same

2001
- 2001-12-20 NZ NZ526674A patent/NZ526674A/en unknown
- 2001-12-20 US US10/250,447 patent/US7122558B2/en not_active Expired - Fee Related
- 2001-12-20 CN CNB018222420A patent/CN1250545C/zh not_active Expired - Fee Related
- 2001-12-20 AU AU2002238471A patent/AU2002238471B2/en not_active Ceased
- 2001-12-20 MX MXPA03005862A patent/MXPA03005862A/es active IP Right Grant
- 2001-12-20 CZ CZ20031812A patent/CZ301209B6/cs not_active IP Right Cessation
- 2001-12-20 RU RU2003123120/04A patent/RU2282629C2/ru not_active IP Right Cessation
- 2001-12-20 HU HU0303524A patent/HUP0303524A3/hu unknown
- 2001-12-20 EP EP01986924A patent/EP1353919B1/en not_active Expired - Lifetime
- 2001-12-20 KR KR1020037008651A patent/KR100869721B1/ko not_active Expired - Fee Related
- 2001-12-20 BR BR0116624-7A patent/BR0116624A/pt not_active Application Discontinuation
- 2001-12-20 PT PT01986924T patent/PT1353919E/pt unknown
- 2001-12-20 JP JP2002555087A patent/JP4295985B2/ja not_active Expired - Fee Related
- 2001-12-20 DK DK01986924T patent/DK1353919T3/da active
- 2001-12-20 ES ES01986924T patent/ES2266291T3/es not_active Expired - Lifetime
- 2001-12-20 WO PCT/EP2001/015168 patent/WO2002053564A2/en not_active Ceased
- 2001-12-20 CA CA2433128A patent/CA2433128C/en not_active Expired - Fee Related
- 2001-12-20 DE DE60121813T patent/DE60121813T2/de not_active Expired - Lifetime
- 2001-12-20 EE EEP200300312A patent/EE05404B1/xx not_active IP Right Cessation
- 2001-12-20 AT AT01986924T patent/ATE334128T1/de active
- 2001-12-20 IL IL15655801A patent/IL156558A0/xx unknown
- 2001-12-20 PL PL01363807A patent/PL363807A1/xx unknown
- 2001-12-20 SI SI200130596T patent/SI1353919T1/sl unknown
- 2001-12-20 UA UA2003066042A patent/UA75626C2/uk unknown
- 2001-12-20 SK SK799-2003A patent/SK287414B6/sk not_active IP Right Cessation
- 2001-12-26 PE PE2001001302A patent/PE20020721A1/es not_active Application Discontinuation
- 2001-12-27 AR ARP010106065A patent/AR032072A1/es unknown
- 2001-12-27 MY MYPI20015907A patent/MY136067A/en unknown
2003
- 2003-06-19 IL IL156558A patent/IL156558A/en not_active IP Right Cessation
- 2003-06-25 EC EC2003004672A patent/ECSP034672A/es unknown
- 2003-06-26 ZA ZA2003/05008A patent/ZA200305008B/en unknown
- 2003-06-27 BG BG107950A patent/BG66162B1/bg unknown
- 2003-06-30 NO NO20033002A patent/NO328772B1/no not_active IP Right Cessation
2006
- 2006-08-31 US US11/514,590 patent/US7879874B2/en not_active Expired - Fee Related
- 2006-08-31 US US11/515,335 patent/US7893087B2/en not_active Expired - Fee Related
- 2006-10-20 CY CY20061101508T patent/CY1105719T1/el unknown
2010
- 2010-05-21 US US12/785,345 patent/US20100234332A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BR0116624A (pt)	2003-12-23
WO2002053564A2 (en)	2002-07-11
US20070105897A1 (en)	2007-05-10
JP2004517123A (ja)	2004-06-10
KR20030067726A (ko)	2003-08-14
EE200300312A (et)	2003-10-15
BG66162B1 (bg)	2011-09-30
CZ20031812A3 (en)	2004-05-12
PL363807A1 (en)	2004-11-29
ECSP034672A (es)	2003-08-29
US20070129398A1 (en)	2007-06-07
EP1353919B1 (en)	2006-07-26
US7893087B2 (en)	2011-02-22
ATE334128T1 (de)	2006-08-15
EP1353919A2 (en)	2003-10-22
ZA200305008B (en)	2005-01-26
NO20033002D0 (no)	2003-06-30
NO20033002L (no)	2003-06-30
BG107950A (bg)	2004-03-31
US20100234332A1 (en)	2010-09-16
HK1055739A1 (en)	2004-01-21
JP4295985B2 (ja)	2009-07-15
US7122558B2 (en)	2006-10-17
KR100869721B1 (ko)	2008-11-21
SK7992003A3 (en)	2004-08-03
US7879874B2 (en)	2011-02-01
HUP0303524A3 (en)	2008-03-28
US20040072863A1 (en)	2004-04-15
NO328772B1 (no)	2010-05-10
EE05404B1 (et)	2011-04-15
SI1353919T1 (sl)	2006-12-31
ES2266291T3 (es)	2007-03-01
AR032072A1 (es)	2003-10-22
MXPA03005862A (es)	2005-09-08
IL156558A0 (en)	2004-01-04
IL156558A (en)	2009-06-15
CN1250545C (zh)	2006-04-12
DE60121813D1 (de)	2006-09-07
HUP0303524A2 (hu)	2004-01-28
CN1487938A (zh)	2004-04-07
NZ526674A (en)	2005-03-24
WO2002053564A3 (en)	2002-10-31
DE60121813T2 (de)	2007-09-20
PT1353919E (pt)	2006-11-30
CY1105719T1 (el)	2010-12-22
PE20020721A1 (es)	2002-10-01
CZ301209B6 (cs)	2009-12-09
UA75626C2 (en)	2006-05-15
AU2002238471B2 (en)	2007-06-28
CA2433128C (en)	2010-05-25
CA2433128A1 (en)	2002-07-11
MY136067A (en)	2008-08-29
RU2003123120A (ru)	2005-01-10
RU2282629C2 (ru)	2006-08-27
SK287414B6 (sk)	2010-09-07

Publication	Publication Date	Title
DK1353919T3 (da)	2006-11-20	Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
DK1329456T3 (da)	2006-12-04	Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
NO20015175L (no)	2001-10-23	Farmasöytisk sammensetning
NO20005913D0 (no)	2000-11-22	Legemiddelsammensetning
NO20020180L (no)	2002-03-13	Nye kinuklidinderivater og medisinske sammensetninger inneholdende det samme
DK1524266T3 (da)	2007-06-25	Farmaceutisk sammensætning
NO20024175L (no)	2002-10-29	Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
AR028204A1 (es)	2003-04-30	Composiciones farmaceuticas electrohiladas
FI20105657L (fi)	2010-06-10	Farmaseuttisia koostumuksia
FI991485L (fi)	2000-12-31	Uusi farmaseuttinen koostumus
IL152451A0 (en)	2003-05-29	2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
PT1242087E (pt)	2004-06-30	Composicoes farmaceuticas
IL153123A0 (en)	2003-06-24	N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
ITMI20010748A0 (it)	2001-04-06	Composizioni farmaceutiche
NO992339D0 (no)	1999-05-14	Farmas°ytiske formuleringer
EE05020B1 (et)	2008-06-16	Glburiidi ravimkoostis
ID27201A (id)	2001-03-08	Komposisi farmasi
NO20026123L (no)	2003-02-18	Farmasöytiske sammensetninger
PT1239832E (pt)	2004-10-29	Composicoes farmaceuticas
NO20031095D0 (no)	2003-03-10	Farmasöytiske sammensetninger
NO20030156D0 (no)	2003-01-13	Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
PT1227817E (pt)	2004-11-30	Composicao farmaceutica aquosa contendo ciclesonida
FI4488U1 (fi)	2000-07-20	Farmaseuttinen koostumus
ID26215A (id)	2000-12-07	Komposisi farmasi
NO20030946D0 (no)	2003-02-28	Medisinske sammensetninger